NPs Basic Information

Name
Chloroxine
Molecular Formula C9H5Cl2NO
IUPAC Name*
5,7-dichloroquinolin-8-ol
SMILES
C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1
InChI
InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
InChIKey
WDFKMLRRRCGAKS-UHFFFAOYSA-N
Synonyms
chloroxine; 773-76-2; 5,7-Dichloroquinolin-8-ol; 5,7-Dichloro-8-hydroxyquinoline; 5,7-Dichloro-8-quinolinol; Capitrol; Chlorquinol; Dichloroxin; Quixalin; Chloroxyquinoline; Dichloroquinolinol; Dikhloroskin; Clofuzid; Endiaron; Quinolor; Dichlorohydroxyquinoline; Chlofucid; Quesyl; 5,7-Dichlorooxine; 5,7-Dichloroxine; 8-QUINOLINOL, 5,7-DICHLORO-; 5,7-Dichloro-8-oxyquinoline; Chlorohydroxyquinoline; Chloroxine [USAN]; 5,7-Dichlor-8-hydroxychinolin; NSC 3904; NSC-3904; MFCD00006786; 2I8BD50I8B; 5,7-Dichloro-8-hydroquinoline; CHEBI:59477; NSC3904; Chloroxine (USAN); AS-229; NCGC00095264-01; DSSTox_CID_2801; DSSTox_RID_76734; DSSTox_GSID_22801; CAS-773-76-2; CCRIS 5751; Capitrol Cream Shampoo; SR-01000747474; EINECS 212-258-3; BRN 0153606; UNII-2I8BD50I8B; 5,7-Dichlor-8-hydroxychinolin [German]; SQ 16401; Capitrol (TN); Spectrum_001434; CHLOROXINE [MI]; 5,7-Dichloro-8-oxine; Spectrum2_000687; Spectrum3_001156; Spectrum4_000744; Spectrum5_001444; CHLOROXINE [VANDF]; 8-Quinolinol,7-dichloro-; CHLOROXINE [MART.]; cid_2722; SCHEMBL3350; 5,7-Dichloro-8-Quinoliol; CHLOROXINE [WHO-DD]; Oprea1_486275; REGID_for_CID_2722; BSPBio_002711; KBioGR_001068; KBioSS_001914; 5-21-03-00286 (Beilstein Handbook Reference); MLS000681736; BIDD:GT0763; DivK1c_000578; SPECTRUM1503202; SPBio_000813; ZINC1131; CHEMBL1200596; CHLOROXINE [ORANGE BOOK]; DTXSID5022801; BDBM32147; HMS501M20; KBio1_000578; KBio2_001914; KBio2_004482; KBio2_007050; KBio3_002211; NINDS_000578; HMS1923K05; HMS2092N04; HMS2609A16; HMS3259E17; HMS3655G16; HMS3712O06; Pharmakon1600-01503202; Capitrol Cream Shampoo (Salt/Mix); AMY23282; component of Capitrol Cream Shampoo; HY-B0295; 5,7-Dichloro-8-quinolinol, 99%; Tox21_111494; AC9195; CCG-40039; NSC758398; s1839; STK075368; 5,7-dichloroquinolin-8-ol;chloroxine; AKOS000271338; Tox21_111494_1; AC-4820; DB01243; NC00505; NSC-758398; IDI1_000578; UPCMLD0ENAT5752182:001; NCGC00095264-02; NCGC00095264-03; NCGC00095264-04; NCGC00095264-05; SMR000312779; SY016017; TG2-36-1; SBI-0051782.P002; A9795; D0412; FT-0623709; SW198618-2; D03472; EN300-207135; AB00052323-08; AB00052323_09; AB00052323_10; SR-01000747474-2; SR-01000747474-3; W-104320; BRD-K17075857-001-06-9; Q12029435; F0918-0943; Z111781330
CAS 773-76-2
PubChem CID 2722
ChEMBL ID CHEMBL1200596
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Quinolines and derivative
        • Subclass: Haloquinolines
          • Direct Parent: Chloroquinolines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 214.04 ALogp: 3.5
HBD: 1 HBA: 2
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 33.1 Aromatic Rings: 2
Heavy Atoms: 13 QED Weighted: 0.718

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.639 MDCK Permeability: 0.00002570
Pgp-inhibitor: 0.007 Pgp-substrate: 0
Human Intestinal Absorption (HIA): 0.003 20% Bioavailability (F20%): 0.031
30% Bioavailability (F30%): 0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.26 Plasma Protein Binding (PPB): 97.84%
Volume Distribution (VD): 1.15 Fu: 1.64%

ADMET: Metabolism

CYP1A2-inhibitor: 0.958 CYP1A2-substrate: 0.744
CYP2C19-inhibitor: 0.309 CYP2C19-substrate: 0.468
CYP2C9-inhibitor: 0.331 CYP2C9-substrate: 0.863
CYP2D6-inhibitor: 0.214 CYP2D6-substrate: 0.619
CYP3A4-inhibitor: 0.078 CYP3A4-substrate: 0.16

ADMET: Excretion

Clearance (CL): 3.863 Half-life (T1/2): 0.363

ADMET: Toxicity

hERG Blockers: 0.027 Human Hepatotoxicity (H-HT): 0.083
Drug-inuced Liver Injury (DILI): 0.945 AMES Toxicity: 0.187
Rat Oral Acute Toxicity: 0.26 Maximum Recommended Daily Dose: 0.19
Skin Sensitization: 0.872 Carcinogencity: 0.507
Eye Corrosion: 0.009 Eye Irritation: 0.786
Respiratory Toxicity: 0.94
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000117 0.277 D02HWP 1.000
ENC002806 0.273 D06AEB 0.532
ENC004703 0.266 D09SOA 0.303
ENC005704 0.264 D00CSQ 0.277
ENC002809 0.263 D01IEM 0.269
ENC000118 0.262 D03SKR 0.267
ENC005702 0.246 D0ZX2G 0.264
ENC000056 0.245 D0TG1H 0.254
ENC001978 0.243 D0T1LK 0.250
ENC005053 0.242 D0W6KM 0.250
*Note: the compound similarity was calculated by RDKIT.